poloxamine 908, 11111-34-5

Articles:

PubMed:	Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
PubMed:	Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth.
PubMed:	Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering.
PubMed:	Modification of the Stewart biphasic colorimetric assay for stable and accurate quantitative determination of Pluronic and Tetronic block copolymers for application in biological systems.
PubMed:	Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays.
PubMed:	Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption.
PubMed:	[Development and estimation of nanosomal rifampicin].
PubMed:	Differences in the adsorption behaviour of poly(ethylene oxide) copolymers onto model polystyrene nanoparticles assessed by isothermal titration microcalorimetry correspond to the biological differences.
PubMed:	A topical w/o/w multiple emulsions prepared with Tetronic 908 as a hydrophilic surfactant: formulation, characterization and release study.
PubMed:	Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting.
PubMed:	Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN).
PubMed:	Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production.
PubMed:	Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908.
PubMed:	Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.
PubMed:	Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.
PubMed:	Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
PubMed:	Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity. Implications in experimental and clinical oncology.
PubMed:	Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages.
PubMed:	Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.
PubMed:	Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: applications in cancer drug delivery and imaging.
PubMed:	Influence of the surfactant concentration on the body distribution of nanoparticles.
PubMed:	Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS.
PubMed:	Physical stability of ethyl diatrizoate nanocrystalline suspension in steam sterilization.
PubMed:	Cloud point of nonionic surfactants: modulation with pharmaceutical excipients.
PubMed:	In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres.
PubMed:	Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.
PubMed:	Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery.
PubMed:	A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats.
PubMed:	Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
PubMed:	Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A 'hepatic-blockade' event or manipulation of nanosphere surface in vivo?
PubMed:	Human serum albumin as a probe for surface conditioning--a study of the ageing effect.
PubMed:	Poly(organo phosphazene) nanoparticles surface modified with poly(ethylene oxide).
PubMed:	Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.
PubMed:	Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.
PubMed:	Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats.
PubMed:	Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum.
PubMed:	An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen.
PubMed:	Effect of splenic congestion associated with haemolytic anaemia on filtration of 'spleen-homing' microspheres.
PubMed:	Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake.
PubMed:	Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles.
PubMed:	The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.